Location History:
- Otsu, JP (2012)
- Osaka, JP (2014)
Company Filing History:
Years Active: 2012-2025
Title: **Mitsuhiro Okuno: Pioneering Antitumor Innovations**
Introduction
Mitsuhiro Okuno, an accomplished inventor based in Otsu, Japan, has made significant contributions to the field of oncology through his innovative research and development. With a total of 4 patents to his name, his work primarily centers around antitumor compositions and novel compounds aimed at combatting cancer effectively.
Latest Patents
Two of Mitsuhiro Okuno’s latest patents showcase his commitment to discovering effective cancer treatments. The first patent involves an **antitumor composition** that combines antitumor agents to effectively shrink tumors while minimizing side effects. This composition includes compound (B) or its salt, which is used in synergy with at least one selected antitumor agent (A) from categories such as alkylating agents, CD20 recognition molecules, and various others.
His second patent introduces **di-substituted pyridine derivatives as anticancers**, which features a novel compound with impressive antitumor effects. This compound is characterized by a specific general formula, highlighting complex structures designed to maximize efficacy against cancer cells.
Career Highlights
Mitsuhiro Okuno plays a pivotal role at Otsuka Pharmaceutical Company, Limited, where he focuses on the development of antitumor therapies. His extensive research and innovative approaches place him at the forefront of cancer treatment advancements. Okuno's contributions have not only led to patent grants but also to the potential improvement of patient outcomes in cancer care.
Collaborations
Throughout his career, Mitsuhiro Okuno has collaborated with notable colleagues such as Yasuo Yanagihara and Takashi Suzuki. These partnerships have been essential for exchanging ideas and enhancing research quality in the competitive field of pharmaceutical innovation.
Conclusion
Mitsuhiro Okuno's inventive work in oncology demonstrates the vital role of creativity and research in addressing complex health challenges. His ongoing innovations and patents continue to hold promise for the future of cancer treatment, paving the way for breakthroughs that could transform patient care.